Evidence map›Paper›PMID 39535854›Full record

ArticleJournal of applied clinical medical physics2025

Enhancing safety: Multi-institutional FMEA and FTA on

Siju C George, Santiago Aguirre, Nichole M Maughan, Ranjini Tolakanahalli, E James Jebaseelan Samuel, Sven L Gallo, Jacqueline E Zoberi, Yongsook C Lee

Abstract readMulticenter Study
In one paragraph

Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Enhancing safety: Multi-institutional FMEA and FTA onJournal of applied clinical medical physics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Siju C GeorgeDepartment of Radiation Oncology, Miami Cancer Institute, Baptist Health, Miami, Florida, USA.ORCID https://orcid.org/0009-0004-5381-6377
Santiago AguirreDepartment of Radiation Oncology, Miami Cancer Institute, Baptist Health, Miami, Florida, USA.ORCID https://orcid.org/0009-0001-5902-1995
Nichole M MaughanDepartment of Radiation Oncology, Intermountain Health, Provo, Utah, USA.ORCID https://orcid.org/0000-0001-7230-9793
Ranjini TolakanahalliDepartment of Radiation Oncology, Miami Cancer Institute, Baptist Health, Miami, Florida, USA.ORCID https://orcid.org/0000-0002-6755-8397
E James Jebaseelan SamuelDepartment of Physics, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, India.ORCID https://orcid.org/0000-0002-8136-2091
Sven L GalloDepartment of Nuclear Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.ORCID https://orcid.org/0009-0003-5221-2363
Jacqueline E ZoberiDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID https://orcid.org/0000-0003-1106-5224
Yongsook C LeeDepartment of Radiation Oncology, Miami Cancer Institute, Baptist Health, Miami, Florida, USA.ORCID https://orcid.org/0000-0003-1941-1291

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study investigates potential failure modes and conducts failure mode and effects analysis (FMEA) and fault tree analysis (FTA) on the administration of

methodsWe reviewed the literature to investigate the administration of Pluvicto and Lutathera, focusing on prospective procedural failures and potential failure modes (PFMs) and their outcomes. We distributed an FMEA survey to multiple experienced centers in

resultsThe findings from the literature review and survey responses on the prospective study have identified several critical areas at risk of failure. These areas include non-optimized treatment delivery, inadequate patient monitoring, and lack of safety training, leading to radiation contamination from the dose excreted by the patients after treatment administration. A segmented FTA was created based on the FMEA results, focusing on radiation contamination with a high RPN value.

conclusionBy identifying the root causes of failures and proposing targeted improvements to the existing QM measures, this analysis enhances safety in treatment delivery of

Indexed as

Radiotherapy DosageHealthcare Failure Mode and Effect AnalysisHumansLutetiumMaleProstatic NeoplasmsQuality Assurance, Health CareRadioisotopesRadiopharmaceuticalsRadiotherapy Planning, Computer-AssistedLutetiumRadioisotopesRadiopharmaceuticalsfailure mode effects analysisfault tree analysisprocess mapprospective analysisquality management

Identifiers

PMID39535854
PMCPMC11712884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.